Your browser doesn't support javascript.
loading
Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan.
Nakano, Yuki; Kurano, Makoto; Morita, Yoshifumi; Shimura, Takuya; Yokoyama, Rin; Qian, Chungen; Xia, Fuzhen; He, Fan; Kishi, Yoshiro; Okada, Jun; Yoshikawa, Naoyuki; Nagura, Yutaka; Okazaki, Hitoshi; Moriya, Kyoji; Seto, Yasuyuki; Kodama, Tatsuhiko; Yatomi, Yutaka.
Afiliación
  • Nakano Y; Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
  • Kurano M; Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan. kurano-tky@umin.ac.jp.
  • Morita Y; Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. kurano-tky@umin.ac.jp.
  • Shimura T; Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
  • Yokoyama R; Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
  • Qian C; Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
  • Xia F; The Key Laboratory for Biomedical Photonics of MOE At Wuhan National Laboratory for Optoelectronics - Hubei Bioinformatics and Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Tec
  • He F; Reagent R&D Center, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, People's Republic of China.
  • Kishi Y; Reagent R&D Center, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, People's Republic of China.
  • Okada J; Business Planning Department, Sales and Marketing Division, Medical and Biological Laboratories Co, Ltd, Tokyo, Japan.
  • Yoshikawa N; Business Planning Department, Sales and Marketing Division, Medical and Biological Laboratories Co, Ltd, Tokyo, Japan.
  • Nagura Y; Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
  • Okazaki H; Department of Blood Transfusion, The University of Tokyo Hospital, Tokyo, Japan.
  • Moriya K; Department of Blood Transfusion, The University of Tokyo Hospital, Tokyo, Japan.
  • Seto Y; Department of Infection Control and Prevention, The University of Tokyo, Tokyo, Japan.
  • Kodama T; Department of Gastrointestinal Surgery, The University of Tokyo, Tokyo, Japan.
  • Yatomi Y; Laboratory for Systems Biology and Medicine, The University of Tokyo, Tokyo, Japan.
Sci Rep ; 11(1): 2776, 2021 02 02.
Article en En | MEDLINE | ID: mdl-33531605
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inmunoglobulina G / Inmunoglobulina M / SARS-CoV-2 / COVID-19 / Especificidad de Anticuerpos Tipo de estudio: Diagnostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inmunoglobulina G / Inmunoglobulina M / SARS-CoV-2 / COVID-19 / Especificidad de Anticuerpos Tipo de estudio: Diagnostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Japón